Key result
Pretreatment serum cholesterol weakly correlates with higher hematocrit in male hypertensive patients.
Answers are grounded in this paper and cite their sources.
There is a weak but significant positive correlation between serum cholesterol and hematocrit levels in male hypertensive patients.
To the Editor. —In 1962, Burch and DePasquale studied the relationship between hematocrit and myocardial infarction and reported that the mean hematocrit in 100 patients with acute myocardial infarction was significantly higher than that in 100 control subjects.1In 1967, Rifkind and Gale observed that hypolipidemia is a common finding in patients with chronic anemia and commented that in underdeveloped countries where anemia is common, there is also a low incidence of ischemic heart disease.2In 1972, Bottiger and Carlson in a study of 2458 healthy nonanemic subjects detected a positive correlation between hemoglobin levels and serum cholesterol and triglyceride levels.3 Due to the recent interest in serum cholesterol levels, we studied the relationship between pretreatment serum cholesterol and hematocrit levels in 200 male patients from our hypertension clinic. As shown in the Figure, we found a weak (r= 0.3) but significant (P<.001) correlation between serum
No takes yet. Share an insight, caveat, or question.
Mahendr S. Kochar (1992) conducted a letter in Hypertension (n=200). Pretreatment serum cholesterol was evaluated on Correlation between serum cholesterol and hematocrit levels (r=0.3, p=<.001). Pretreatment serum cholesterol showed a weak but significant positive correlation with hematocrit levels (r=0.3, P<0.001) in male patients with hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: